TuHURA Biosciences, Inc. (HURA) Stock
Valuation
Financials & Margins
Annual Financials (USD)
Balance Sheet (USD)
Latest News
Cash Flow (USD)
Valuation & Return Ratios
Peer Comparison
About TuHURA Biosciences, Inc.
TuHURA Biosciences, Inc. is led by CEO James A. Bianco, employs 19 people, headquartered in US, publicly traded since 2013.
TuHURA Biosciences, Inc. (HURA) stock trades at $2.18 with a market capitalization of $138.92M. The stock is valued at a negative price-to-earnings (P/E) ratio of -3.46, reflecting a net loss over the last twelve months, price-to-book of 6.47, price-to-sales of 0.00. Over the past 52 weeks the stock has ranged between $0.41 and $3.43, and currently trades 36.4% below its 52-week high.
On profitability, TuHURA Biosciences, Inc. generates a return on equity (ROE) of -154.32% (negative, reflecting a net loss), return on capital employed of -138.70%.
TuHURA Biosciences, Inc. by the numbers, 2016–2025
Between 2016 and 2025 TuHURA Biosciences, Inc. reported revenue of $0 rising to $0. Compounded, revenue has grown —% a year over five years, —% over three, —% over the last twelve months. Net profit fell to $-30.0M.
On a trailing twelve-month basis to Jun '26, revenue is $0 and net profit $-31.0M.
Borrowings stand at $1.0M, cash from operations was $-28.0M in the latest year, positive in 0 of the last 10.
Return on equity has averaged 457.1% over five years, and was -142.9% in the most recent year.
The share price itself has compounded at -76.6% a year over five years, -73.5% over three, -4.3% over the last year. Past price movement is history, not a forecast.
Figures are as reported and in the company's own reporting currency. They describe what has already happened and carry no implication about what follows.
TuHURA Biosciences, Inc. (HURA) — frequently asked questions
What is TuHURA Biosciences, Inc. (HURA) stock price today?
TuHURA Biosciences, Inc. (HURA) is currently trading at $2.18, up 8.46% today.
What is HURA P/E ratio?
TuHURA Biosciences, Inc.'s P/E ratio is -3.46. A negative P/E means the company reported a net loss over the last twelve months, so P/E is not a meaningful valuation measure for it right now.
What is HURA return on equity (ROE)?
TuHURA Biosciences, Inc.'s return on equity (ROE) is -154.32%. ROE measures net income relative to shareholders' equity. A negative ROE means the company reported a net loss over the period.
What is TuHURA Biosciences, Inc.'s market cap?
TuHURA Biosciences, Inc. has a market capitalization of $138.92M.
Does HURA pay a dividend?
TuHURA Biosciences, Inc. is not currently showing a dividend yield in our data, which means no recent cash dividend was recorded for it.
How much debt does HURA carry?
TuHURA Biosciences, Inc. has a debt-to-equity ratio of 0.02. That compares total borrowings with shareholders' equity: a figure under 1 means equity exceeds debt.
What is HURA's profit margin?
TuHURA Biosciences, Inc. reports a net profit margin of 0.00% — the share of revenue left after every cost, including tax and interest.
What sector is HURA in?
TuHURA Biosciences, Inc. is classified under Healthcare, in the Biotechnology industry. Ratios are most informative compared with other companies in the same industry rather than across the whole market.
Which exchange is HURA listed on?
TuHURA Biosciences, Inc. trades on NASDAQ under the ticker HURA.
What is HURA's 52-week range?
Over the last year TuHURA Biosciences, Inc. has traded between $0.41 and $3.43.
Related Healthcare Stocks
Popular Stocks
Screens HURA currently matches
On the figures above, TuHURA Biosciences, Inc. passes the filters for 6 of our ready-made screens, among them Day Gainers Stocks, Penny Stocks, Stocks Under $5. Appearing on a screen means the numbers meet its filters today and nothing more; the list is rebuilt whenever the data changes.
Related stock screens
Data for information only, not investment advice. Figures may be delayed or inaccurate; verify against company filings. See our disclaimer.